Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SPIRONOLACTONE Cause C-reactive protein increased? 57 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of C-reactive protein increased have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.3% of all adverse event reports for SPIRONOLACTONE.

57
Reports of C-reactive protein increased with SPIRONOLACTONE
0.3%
of all SPIRONOLACTONE reports
12
Deaths
55
Hospitalizations

How Dangerous Is C-reactive protein increased From SPIRONOLACTONE?

Of the 57 reports, 12 (21.1%) resulted in death, 55 (96.5%) required hospitalization, and 3 (5.3%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 57 reports have been filed with the FAERS database.

What Other Side Effects Does SPIRONOLACTONE Cause?

Acute kidney injury (3,273) Hyperkalaemia (2,518) Hypotension (1,583) Dyspnoea (1,468) Drug ineffective (1,379) Hyponatraemia (1,166) Dizziness (991) Fatigue (990) Fall (947) Off label use (899)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which SPIRONOLACTONE Alternatives Have Lower C-reactive protein increased Risk?

SPIRONOLACTONE vs SPRYCEL SPIRONOLACTONE vs STALEVO SPIRONOLACTONE vs STANNOUS FLUORIDE SPIRONOLACTONE vs STANOZOLOL SPIRONOLACTONE vs STAVUDINE

Related Pages

SPIRONOLACTONE Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased SPIRONOLACTONE Demographics